On Jan. 24, 2024, the Securities and Exchange Commission (SEC) adopted final rules that significantly expand disclosure and other requirements for initial public offerings (IPOs) by special purpose ...
Primary Endpoint achieved as required for United States Food and Drug Administration (FDA) submission Sydney, Australia and Bedminster, New Jersey - QRxPharma (ASX: QRX and OTCQX: QRXPY) announced ...
Navigating FDA's rules to get a fixed-dose combination therapy for chronic obstructive pulmonary disease approved required a large study and a specific population. When GlaxoSmithKline designed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results